At a large virology campus in Siberia called VECTOR, a sudden explosion in September blew out the windows and set parts of a building ablaze.
Experts from nine Central African nations met to advance biosafety and biosecurity in the region. Participants agreed to set biosecurity and biosafety capacity building goals for the region and track progress.
The US Centers for Disease Control and Prevention's (CDC) 16th International Biosafety Symposium, which will focus on "The Power of Risk Assessment."
Automated benchtop systems are beginning to integrate oligonucleotide synthesis and protein production. Given economic pressures to innovate in drug manufacture and the potential of platform production technologies to enable decentralization, a future in which the brand manufacturers’ monopoly on biologics could be broken is feasible.
DIY CRISPR kits are under the US Food and Drug Administration's (FDA) jurisdiction, but the FDA has not yet enforced any standards for biohackers.
Three full days of state-of-the-art keynotes, papers, and panels highlighting best practices and hands-on skills crucial for today’s biosafety and biosecurity professionals.
A body bag has been designed to prevent further Ebola infections while also taking into account the social and cultural operating envrionment.
Study finds that nanofibers have the possibility to enhance mask and respirator capability to capture nanoparticles like viruses and bacteria.
Cloud labs facilitate citizen and crowd-performed science. And while cloud labs may offer endless possibilities for experimentation, not all research will be for good purposes.
Twin girls whose genomes were editied to make them resistant to HIV might have a shortened life expectancy as people with two disabled copies of the CCR5 gene — which protects against HIV infection — are 21 percent more likely to die before the age of 76 when compared to people with at least one working copy of the gene.